{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T04:54:27Z","timestamp":1764132867293},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"33","license":[{"start":{"date-parts":[[2014,11,24]],"date-time":"2014-11-24T00:00:00Z","timestamp":1416787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,11,24]],"date-time":"2014-11-24T00:00:00Z","timestamp":1416787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2015,8,13]]},"DOI":"10.1038\/onc.2014.364","type":"journal-article","created":{"date-parts":[[2014,11,24]],"date-time":"2014-11-24T10:59:03Z","timestamp":1416826743000},"page":"4347-4357","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Cks1 is a critical regulator of hematopoietic stem cell quiescence and cycling, operating upstream of Cdk inhibitors"],"prefix":"10.1038","volume":"34","author":[{"given":"V","family":"Tomiatti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Istv\u00e1nffy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Pietschmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Kratzat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Hoellein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Quintanilla-Fend","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"von Bubnoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Peschel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R A J","family":"Oostendorp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U","family":"Keller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,11,24]]},"reference":[{"key":"BFonc2014364_CR1","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1083\/jcb.201102131","volume":"195","author":"EM Pietras","year":"2011","unstructured":"Pietras EM, Warr MR, Passegue E . Cell cycle regulation in hematopoietic stem cells. J Cell Biol 2011; 195: 709\u2013720.","journal-title":"J Cell Biol"},{"key":"BFonc2014364_CR2","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.stem.2011.08.005","volume":"9","author":"M Tesio","year":"2011","unstructured":"Tesio M, Trumpp A . Breaking the cell cycle of HSCs by p57 and friends. Cell Stem Cell 2011; 9: 187\u2013192.","journal-title":"Cell Stem Cell"},{"key":"BFonc2014364_CR3","doi-asserted-by":"publisher","first-page":"7256","DOI":"10.1038\/sj.onc.1207945","volume":"23","author":"T Cheng","year":"2004","unstructured":"Cheng T . Cell cycle inhibitors in normal and tumor stem cells. Oncogene 2004; 23: 7256\u20137266.","journal-title":"Oncogene"},{"key":"BFonc2014364_CR4","doi-asserted-by":"publisher","first-page":"2925","DOI":"10.1038\/onc.2009.170","volume":"28","author":"A Satyanarayana","year":"2009","unstructured":"Satyanarayana A, Kaldis P . Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms. Oncogene 2009; 28: 2925\u20132939.","journal-title":"Oncogene"},{"key":"BFonc2014364_CR5","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1016\/j.bbagen.2012.07.004","volume":"1830","author":"A Matsumoto","year":"2013","unstructured":"Matsumoto A, Nakayama KI . Role of key regulators of the cell cycle in maintenance of hematopoietic stem cells. Biochim Biophys Acta 2013; 1830: 2335\u20132344.","journal-title":"Biochim Biophys Acta"},{"key":"BFonc2014364_CR6","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/81335","volume":"6","author":"T Cheng","year":"2000","unstructured":"Cheng T, Rodrigues N, Dombkowski D, Stier S, Scadden DT . Stem cell repopulation efficiency but not pool size is governed by p27(kip1). Nat Med 2000; 6: 1235\u20131240.","journal-title":"Nat Med"},{"key":"BFonc2014364_CR7","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.stem.2011.06.014","volume":"9","author":"A Matsumoto","year":"2011","unstructured":"Matsumoto A, Takeishi S, Kanie T, Susaki E, Onoyama I, Tateishi Y et al. p57 Is Required for quiescence and maintenance of adult hematopoietic stem cells. Cell Stem Cell 2011; 9: 262\u2013271.","journal-title":"Cell Stem Cell"},{"key":"BFonc2014364_CR8","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.stem.2011.07.003","volume":"9","author":"P Zou","year":"2011","unstructured":"Zou P, Yoshihara H, Hosokawa K, Tai I, Shinmyozu K, Tsukahara F et al. p57(KiP2) and p27(Kip1) cooperate to maintain hematopoietic stem cell quiescence through interactions with Hsc70. Cell Stem Cell 2011; 9: 247\u2013261.","journal-title":"Cell Stem Cell"},{"key":"BFonc2014364_CR9","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.0.CO;2-I","volume":"183","author":"J Slingerland","year":"2000","unstructured":"Slingerland J, Pagano M . Regulation of the cdk inhibitor p27 and its deregulation in cancer. J Cell Physiol 2000; 183: 10\u201317.","journal-title":"J Cell Physiol"},{"key":"BFonc2014364_CR10","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1182\/blood-2007-06-095570","volume":"111","author":"E Le Toriellec","year":"2008","unstructured":"Le Toriellec E, Despouy G, Pierron G, Gaye N, Joiner M, Bellanger D et al. Haploinsufficiency of CDKN1B contributes to leukemogenesis in T-cell prolymphocytic leukemia. Blood 2008; 111: 2321\u20132328.","journal-title":"Blood"},{"key":"BFonc2014364_CR11","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/S0959-437X(98)80059-2","volume":"8","author":"W Krek","year":"1998","unstructured":"Krek W . Proteolysis and the G1-S transition: the SCF connection. Curr Opin Genet Dev 1998; 8: 36\u201342.","journal-title":"Curr Opin Genet Dev"},{"key":"BFonc2014364_CR12","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/S1097-2765(01)00210-6","volume":"7","author":"C Spruck","year":"2001","unstructured":"Spruck C, Strohmaier H, Watson M, Smith APL, Ryan A, Krek W et al. A CDK-independent function of mammalian Cks1: targeting of SCFSkp2 to the CDK inhibitor p27(Kip1). Mol Cell 2001; 7: 639\u2013650.","journal-title":"Mol Cell"},{"key":"BFonc2014364_CR13","doi-asserted-by":"publisher","first-page":"11324","DOI":"10.1073\/pnas.95.19.11324","volume":"95","author":"ZK Yu","year":"1998","unstructured":"Yu ZK, Gervais JLM, Zhang H . Human CUL-1 associates with the SKP1\/SKP2 complex and regulates p21(CIP1\/WAF1) and cyclin D proteins. Proc Natl Acad Sci USA 1998; 95: 11324\u201311329.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2014364_CR14","doi-asserted-by":"publisher","first-page":"10231","DOI":"10.1073\/pnas.1831009100","volume":"100","author":"T Kamura","year":"2003","unstructured":"Kamura T, Hara T, Kotoshiba S, Yada M, Ishida N, Imaki H et al. Degradation of p57(Kip2) mediated by SCFSkp2 - dependent ubiquitylation. Proc Natl Acad Sci USA 2003; 100: 10231\u201310236.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2014364_CR15","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1101\/gad.1011202","volume":"16","author":"D Tedesco","year":"2002","unstructured":"Tedesco D, Lukas J, Reed SI . The pRb-related protein p130 is regulated by phosphorylation-dependent proteolysis via the protein-ubiquitin ligase SCFSkp2. Genes Dev 2002; 16: 2946\u20132957.","journal-title":"Genes Dev"},{"key":"BFonc2014364_CR16","doi-asserted-by":"publisher","first-page":"6509","DOI":"10.1182\/blood-2010-11-321521","volume":"117","author":"S Rodriguez","year":"2011","unstructured":"Rodriguez S, Wang L, Mumaw C, Srour EF, Lo Celso C, Nakayama K et al. The SKP2 E3 ligase regulates basal homeostasis and stress-induced regeneration of HSCs. Blood 2011; 117: 6509\u20136519.","journal-title":"Blood"},{"key":"BFonc2014364_CR17","doi-asserted-by":"publisher","first-page":"5429","DOI":"10.1182\/blood-2010-10-312785","volume":"118","author":"J Wang","year":"2011","unstructured":"Wang J, Han F, Wu J, Lee SW, Chan CH, Wu CY et al. The role of Skp2 in hematopoietic stem cell quiescence, pool size, and self-renewal. Blood 2011; 118: 5429\u20135438.","journal-title":"Blood"},{"key":"BFonc2014364_CR18","doi-asserted-by":"publisher","first-page":"11393","DOI":"10.1158\/0008-5472.CAN-06-4173","volume":"67","author":"L Westbrook","year":"2007","unstructured":"Westbrook L, Manuvakhova M, Kern FG, Estes NR, Ramanathan HN, Thottassery JV . Cks1 regulates cdk1 expression: a novel role during mitotic entry in breast cancer cells. Cancer Res 2007; 67: 11393\u201311401.","journal-title":"Cancer Res"},{"key":"BFonc2014364_CR19","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1128\/MCB.06771-11","volume":"32","author":"A Hoellein","year":"2012","unstructured":"Hoellein A, Graf S, Bassermann F, Schoeffmann S, Platz U, Holzlwimmer G et al. Cks1 promotion of S phase entry and proliferation is independent of p27Kip1 suppression. Mol Cell Biol 2012; 32: 2416\u20132427.","journal-title":"Mol Cell Biol"},{"key":"BFonc2014364_CR20","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/nrc2396","volume":"8","author":"D Frescas","year":"2008","unstructured":"Frescas D, Pagano M . Deregulated proteolysis by the F-box proteins SKP2 and beta-TrCP: tipping the scales of cancer. Nat Rev Cancer 2008; 8: 438\u2013449.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2014364_CR21","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1084\/jem.20091318","volume":"207","author":"Y Morita","year":"2010","unstructured":"Morita Y, Ema H, Nakauchi H . Heterogeneity and hierarchy within the most primitive hematopoietic stem cell compartment. J Exp Med 2010; 207: 1173\u20131182.","journal-title":"J Exp Med"},{"key":"BFonc2014364_CR22","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1126\/science.287.5459.1804","volume":"287","author":"T Cheng","year":"2000","unstructured":"Cheng T, Rodrigues N, Shen HM, Yang YG, Dombkowski D, Sykes M et al. Hematopoietic stem cell quiescence maintained by p21(cip1\/waf1). Science 2000; 287: 1804\u20131808.","journal-title":"Science"},{"key":"BFonc2014364_CR23","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.cell.2008.10.048","volume":"135","author":"A Wilson","year":"2008","unstructured":"Wilson A, Laurenti E, Oser G, van der Wath RC, Blanco-Bose W, Jaworski M et al. Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair. Cell 2008; 135: 1118\u20131129.","journal-title":"Cell"},{"key":"BFonc2014364_CR24","first-page":"114","volume":"18","author":"C Lerner","year":"1990","unstructured":"Lerner C, Harrison DE . 5-fluorouracil spares hematopoietic stem-cells responsible for long-term repopulation. Exp Hematol 1990; 18: 114\u2013118.","journal-title":"Exp Hematol"},{"key":"BFonc2014364_CR25","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1172\/JCI41246","volume":"120","author":"D Perrotti","year":"2010","unstructured":"Perrotti D, Jamieson C, Goldman J, Skorski T . Chronic myeloid leukemia: mechanisms of blastic transformation. J Clin Invest 2010; 120: 2254\u20132264.","journal-title":"J Clin Invest"},{"key":"BFonc2014364_CR26","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/nrc1567","volume":"5","author":"R Ren","year":"2005","unstructured":"Ren R . Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia. Nat Rev Cancer 2005; 5: 172\u2013183.","journal-title":"Nat Rev Cancer"},{"key":"BFonc2014364_CR27","first-page":"839","volume":"12","author":"M Sattler","year":"1996","unstructured":"Sattler M, Salgia R, Okuda K, Uemura N, Durstin MA, Pisick E et al. The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR\/ABL and p210BCR\/ABL to the phosphatidylinositol-3\u2032 kinase pathway. Oncogene 1996; 12: 839\u2013846.","journal-title":"Oncogene"},{"key":"BFonc2014364_CR28","doi-asserted-by":"publisher","first-page":"798592","DOI":"10.1155\/2011\/798592","volume":"2011","author":"M Affer","year":"2011","unstructured":"Affer M, Dao S, Liu C, Olshen AB, Mo Q, Viale A et al. Gene expression differences between enriched normal and chronic myelogenous leukemia quiescent stem\/progenitor cells and correlations with biological abnormalities. J Oncol 2011; 2011: 798592.","journal-title":"J Oncol"},{"key":"BFonc2014364_CR29","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/leu.2008.337","volume":"23","author":"D Bruennert","year":"2009","unstructured":"Bruennert D, Czibere A, Bruns I, Kronenwett R, Gattermann N, Haas R et al. Early in vivo changes of the transcriptome in Philadelphia chromosome-positive CD34+ cells from patients with chronic myelogenous leukaemia following imatinib therapy. Leukemia 2009; 23: 983\u2013985.","journal-title":"Leukemia"},{"key":"BFonc2014364_CR30","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.stem.2008.07.009","volume":"3","author":"P Viatour","year":"2008","unstructured":"Viatour P, Somervaille TC, Venkatasubrahmanyam S, Kogan S, McLaughlin ME, Weissman IL et al. Hematopoietic stem cell quiescence is maintained by compound contributions of the retinoblastoma gene family. Cell Stem Cell 2008; 3: 416\u2013428.","journal-title":"Cell Stem Cell"},{"key":"BFonc2014364_CR31","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.stem.2012.08.006","volume":"11","author":"L Rossi","year":"2012","unstructured":"Rossi L, Lin KK, Boles NC, Yang L, King KY, Jeong M et al. Less is more: unveiling the functional core of hematopoietic stem cells through knockout mice. Cell Stem Cell 2012; 11: 302\u2013317.","journal-title":"Cell Stem Cell"},{"key":"BFonc2014364_CR32","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/nrm3582","volume":"14","author":"JR Skaar","year":"2013","unstructured":"Skaar JR, Pagan JK, Pagano M . Mechanisms and function of substrate recruitment by F-box proteins. Nat Rev Mol Cell Biol 2013; 14: 369\u2013381.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFonc2014364_CR33","doi-asserted-by":"publisher","first-page":"4995","DOI":"10.1182\/blood-2006-07-038703","volume":"109","author":"F Zhan","year":"2007","unstructured":"Zhan F, Colla S, Wu X, Chen B, Stewart JP, Kuehl WM et al. CKS1B, overexpressed in aggressive disease, regulates multiple myeloma growth and survival through SKP2- and p27Kip1-dependent and -independent mechanisms. Blood 2007; 109: 4995\u20135001.","journal-title":"Blood"},{"key":"BFonc2014364_CR34","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1080\/07357900802239116","volume":"27","author":"RM Nagler","year":"2009","unstructured":"Nagler RM, Ben-Izhak O, Ostrovsky D, Golz A, Hershko DD . The expression and prognostic significance of Cks1 in salivary cancer. Cancer Invest 2009; 27: 512\u2013520.","journal-title":"Cancer Invest"},{"key":"BFonc2014364_CR35","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1038\/sj.emboj.7601691","volume":"26","author":"UB Keller","year":"2007","unstructured":"Keller UB, Old JB, Dorsey FC, Nilsson JA, Nilsson L, MacLean KH et al. Myc targets Cks1 to provoke the suppression of p27Kip1, proliferation and lymphomagenesis. EMBO J 2007; 26: 2562\u20132574.","journal-title":"EMBO J"},{"key":"BFonc2014364_CR36","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1038\/onc.2012.246","volume":"32","author":"MT Gomez-Casares","year":"2013","unstructured":"Gomez-Casares MT, Garcia-Alegria E, Lopez-Jorge CE, Ferrandiz N, Blanco R, Alvarez S et al. MYC antagonizes the differentiation induced by imatinib in chronic myeloid leukemia cells through downregulation of p27(KIP1.). Oncogene 2013; 32: 2239\u20132246.","journal-title":"Oncogene"},{"key":"BFonc2014364_CR37","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/ng.2350","volume":"44","author":"HJ Zhang","year":"2012","unstructured":"Zhang HJ, Peng C, Hu YG, Li HW, Sheng Z, Chen YY et al. The Blk pathway functions as a tumor suppressor in chronic myeloid leukemia stem cells. Nat Genet 2012; 44: 861\u2013871.","journal-title":"Nat Genet"},{"key":"BFonc2014364_CR38","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.cell.2013.06.048","volume":"154","author":"CH Chan","year":"2013","unstructured":"Chan CH, Morrow JK, Li CF, Gao Y, Jin G, Moten A et al. Pharmacological inactivation of Skp2 SCF ubiquitin ligase restricts cancer stem cell traits and cancer progression. Cell 2013; 154: 556\u2013568.","journal-title":"Cell"},{"key":"BFonc2014364_CR39","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1158\/1541-7786.MCR-09-0232","volume":"8","author":"JB Old","year":"2010","unstructured":"Old JB, Kratzat S, Hoellein A, Graf S, Nilsson JA, Nilsson L et al. Skp2 directs Myc-mediated suppression of p27Kip1 yet has modest effects on Myc-driven lymphomagenesis. Mol Cancer Res 2010; 8: 353\u2013362.","journal-title":"Mol Cancer Res"},{"key":"BFonc2014364_CR40","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.1038\/sj.onc.1201450","volume":"15","author":"X Wang","year":"1997","unstructured":"Wang X, Gorospe M, Huang Y, Holbrook NJ . p27Kip1 overexpression causes apoptotic death of mammalian cells. Oncogene 1997; 15: 2991\u20132997.","journal-title":"Oncogene"},{"key":"BFonc2014364_CR41","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.ccr.2013.09.021","volume":"24","author":"HL Zhao","year":"2013","unstructured":"Zhao HL, Bauzon F, Fu H, Lu ZL, Cui JH, Nakayama K et al. Skp2 deletion unmasks a p27 safeguard that blocks tumorigenesis in the absence of pRb and p53 tumor suppressors. Cancer Cell 2013; 24: 645\u2013659.","journal-title":"Cancer Cell"},{"key":"BFonc2014364_CR42","doi-asserted-by":"publisher","first-page":"3463","DOI":"10.1038\/ncomms4463","volume":"5","author":"Z Lu","year":"2014","unstructured":"Lu Z, Bauzon F, Fu H, Cui J, Zhao H, Nakayama K et al. Skp2 suppresses apoptosis in Rb1-deficient tumours by limiting E2F1 activity. Nat Commun 2014; 5: 3463.","journal-title":"Nat Commun"},{"key":"BFonc2014364_CR43","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.1182\/blood-2010-05-287235","volume":"118","author":"R Istvanffy","year":"2011","unstructured":"Istvanffy R, Kroger M, Eckl C, Gitzelmann S, Vilne B, Bock F et al. Stromal pleiotrophin regulates repopulation behavior of hematopoietic stem cells. Blood 2011; 118: 2712\u20132722.","journal-title":"Blood"},{"key":"BFonc2014364_CR44","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1182\/blood.V92.10.3780","volume":"92","author":"WS Pear","year":"1998","unstructured":"Pear WS, Miller JP, Xu L, Pui JC, Soffer B, Quackenbush RC et al. Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr\/abl-transduced bone marrow. Blood 1998; 92: 3780\u20133792.","journal-title":"Blood"},{"key":"BFonc2014364_CR45","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/sj.leu.2404151","volume":"20","author":"C Miething","year":"2006","unstructured":"Miething C, Feihl S, Mugler C, Grundler R, von Bubnoff N, Lordick F et al. The Bcr-Abl mutations T315I and Y253H do not confer a growth advantage in the absence of imatinib. Leukemia 2006; 20: 650\u2013657.","journal-title":"Leukemia"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2014364.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2014364","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2014364.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T20:35:52Z","timestamp":1647894952000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2014364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,24]]},"references-count":45,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2015,8,13]]}},"alternative-id":["BFonc2014364"],"URL":"https:\/\/doi.org\/10.1038\/onc.2014.364","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,24]]},"assertion":[{"value":"14 April 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}